Literature DB >> 23816937

American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary.

Alan J Garber, Martin J Abrahamson, Joshua I Barzilay, Lawrence Blonde, Zachary T Bloomgarden, Michael A Bush, Samuel Dagogo-Jack, Michael B Davidson, Daniel Einhorn, W Timothy Garvey, George Grunberger, Yehuda Handelsman, Irl B Hirsch, Paul S Jellinger, Janet B McGill, Jeffrey I Mechanick, Paul D Rosenblit, Guillermo E Umpierrez, Michael H Davidson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23816937      PMCID： PMC4142590          DOI： 10.4158/EP13176.CS

Source DB:  PubMed          Journal:  Endocr Pract        ISSN： 1530-891X            Impact factor:   3.443


× No keyword cloud information.
  105 in total

1.  Facilitation of ß-cell K(ATP) channel sulfonylurea sensitivity by a cAMP analog selective for the cAMP-regulated guanine nucleotide exchange factor Epac.

Authors:  Colin A Leech; Igor Dzhura; Oleg G Chepurny; Frank Schwede; Hans-G Genieser; George G Holz
Journal:  Islets       Date:  2010 Mar-Apr       Impact factor: 2.694

2.  Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome.

Authors:  Leila Azadbakht; Parvin Mirmiran; Ahmad Esmaillzadeh; Tohid Azizi; Fereidoun Azizi
Journal:  Diabetes Care       Date:  2005-12       Impact factor: 19.112

Review 3.  Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis.

Authors:  C F Deacon; E Mannucci; B Ahrén
Journal:  Diabetes Obes Metab       Date:  2012-04-24       Impact factor: 6.577

4.  Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study.

Authors:  Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Leonelo Bautista; Maria Grazia Franzosi; Patrick Commerford; Chim C Lang; Zvonko Rumboldt; Churchill L Onen; Liu Lisheng; Supachai Tanomsup; Paul Wangai; Fahad Razak; Arya M Sharma; Sonia S Anand
Journal:  Lancet       Date:  2005-11-05       Impact factor: 79.321

5.  Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Authors:  William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

6.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

Authors: 
Journal:  Lancet       Date:  2000-01-22       Impact factor: 79.321

7.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

8.  Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study.

Authors:  Christianne L Roumie; Adriana M Hung; Robert A Greevy; Carlos G Grijalva; Xulei Liu; Harvey J Murff; Tom A Elasy; Marie R Griffin
Journal:  Ann Intern Med       Date:  2012-11-06       Impact factor: 25.391

9.  A meta-analysis of alcohol consumption and the risk of 15 diseases.

Authors:  Giovanni Corrao; Vincenzo Bagnardi; Antonella Zambon; Carlo La Vecchia
Journal:  Prev Med       Date:  2004-05       Impact factor: 4.018

10.  Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration.

Authors: 
Journal:  Diabetologia       Date:  2007-04-06       Impact factor: 10.122
View more
  102 in total

1.  Learning Effective Treatment Pathways for Type-2 Diabetes from a clinical data warehouse.

Authors:  Rohit Vashisht; Ken Jung; Nigam Shah
Journal:  AMIA Annu Symp Proc       Date:  2017-02-10

2.  Optimizing the Care of Patients With Type 2 Diabetes Using Incretin-Based Therapy: Focus on GLP-1 Receptor Agonists.

Authors:  Mansur Shomali
Journal:  Clin Diabetes       Date:  2014-01

3.  Trulicity (Dulaglutide): A New GLP-1 Receptor Agonist Once-Weekly Subcutaneous Injection Approved for the Treatment of Patients with Type 2 Diabetes.

Authors:  Loretta Fala
Journal:  Am Health Drug Benefits       Date:  2015-03

4.  Tanzeum (Albiglutide): A Once-Weekly GLP-1 Receptor Agonist Subcutaneous Injection Approved for the Treatment of Patients with Type 2 Diabetes.

Authors:  Loretta Fala
Journal:  Am Health Drug Benefits       Date:  2015-03

5.  Invokamet (Canagliflozin plus Metformin HCl): First Fixed-Dose Combination with an SGLT2 Inhibitor Approved for the Treatment of Patients with Type 2 Diabetes.

Authors:  Loretta Fala
Journal:  Am Health Drug Benefits       Date:  2015-03

6.  Diabetes Disease Severity Was Not Associated with Risk of Deep Infection or Revision After Shoulder Arthroplasty.

Authors:  Matthew D McElvany; Priscilla H Chan; Heather A Prentice; Elizabeth W Paxton; Mark T Dillon; Ronald A Navarro
Journal:  Clin Orthop Relat Res       Date:  2019-06       Impact factor: 4.176

7.  Changing Patterns of Glucose-Lowering Medication Use in VA Nursing Home Residents With Diabetes, 2005 to 2011.

Authors:  Sei J Lee; Irena Stijacic-Cenzer; Caroline Barnhart; Keelan McClymont; Michael A Steinman
Journal:  J Am Med Dir Assoc       Date:  2015-08-10       Impact factor: 4.669

8.  Edmonton obesity staging system among pediatric patients: a validation and obesogenic risk factor analysis.

Authors:  M G Grammatikopoulou; M Chourdakis; K Gkiouras; P Roumeli; D Poulimeneas; E Apostolidou; I Chountalas; I Tirodimos; O Filippou; S Papadakou-Lagogianni; T Dardavessis
Journal:  J Endocrinol Invest       Date:  2018-01-08       Impact factor: 4.256

Review 9.  The 2013 American Association of Clinical Endocrinologists' diabetes mellitus management recommendations: improvements needed.

Authors:  Michael R Gionfriddo; Rozalina G McCoy; Kasia J Lipska
Journal:  JAMA Intern Med       Date:  2014-02-01       Impact factor: 21.873

10.  Investigation of Motivational Interviewing and Prevention Consults to Achieve Cardiovascular Targets (IMPACT) trial.

Authors:  Eugenia Gianos; Antoinette Schoenthaler; Yu Guo; Judy Zhong; Howard Weintraub; Arthur Schwartzbard; James Underberg; Michael Schloss; Jonathan D Newman; Sean Heffron; Edward A Fisher; Jeffrey S Berger
Journal:  Am Heart J       Date:  2018-01-09       Impact factor: 4.749
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.